Lin Yu-ting cleared to return to women’s boxing competition

Olympic champion Lin Yu-ting has been authorised to take part in women’s boxing after World Boxing confirmed she met the organisation’s new qualification requirements. The 30-year-old Taiwanese pugilist, who won the women’s featherweight title for Chinese Taipei at the 2024 Paris Olympics, had become caught up in a prominent qualification controversy alongside Algeria’s Imane Khelif. Both boxers were formerly banned from the 2023 World Championships by the International Boxing Association, which cited non-compliance with female competition requirements. World Boxing, which assumed oversight of the sport at Olympic level following the IOC’s suspension of the IBA, introduced mandatory sex testing in August 2025. Lin’s approval follows a finished appeals procedure and health assessment by World Boxing’s independent experts.

The eligibility row that shook Olympic boxing

Lin Yu-ting’s clearance signals a significant turning point in one of Olympic sports’ most disputed qualification controversies. The dispute emerged when the IBA banned both Lin and Khelif from the 2023 World Championship event, claiming they had fallen short of the requirements for participation in women’s competitions. Notwithstanding this decision, Lin proceeded to claim Olympic gold in Paris just months later, performing under IOC supervision after the sports body revoked the IBA of its status due to significant integrity and governance issues. The incident highlighted deep divisions within boxing administration and raised intricate questions about testing for eligibility and equity in women’s sport.

The dispute heightened the scrutiny regarding qualification standards in female boxing at the highest levels of competition. Lin’s absence from numerous competitions following the governing body’s introduction of required sex verification in August 2025 highlighted the lack of clarity regarding her eligibility. The appeals procedure, even if detailed and eventually cleared the boxer, illustrated the psychological and career impact of extended qualification disputes. World Boxing’s choice to introduce impartial clinical assessment procedures signified an attempt to establish clearer, more transparent standards for the activity in future.

• IBA excluded Lin and Khelif from 2023 World Championships
• IOC removed IBA citing integrity issues and poor governance
• Lin secured Olympic gold despite eligibility concerns in Paris
• World Boxing introduced mandatory sex testing in August 2025

World Boxing’s new testing regime outlined

World Boxing’s compulsory sex screening policy, established in August 2025, constitutes a fundamental shift in how the sport handles eligibility assessment. The new regime focuses on a specific genetic test designed to establish biological sex through scientific analysis, superseding the former approach that had generated widespread controversy. This approach aims to deliver objective, measurable criteria that World Boxing argues will safeguard both competitive fairness and competitor welfare. The policy covers all competitors in women’s divisions and includes a formal appeals procedure, allowing athletes to dispute initial findings with accompanying medical documentation. This structure is designed to establish consistency and transparency across international boxing competitions.

The implementation of required testing procedures has shown considerable value for athletes like Lin Yu-ting, who encountered sustained doubt whilst the updated protocol was introduced. World Boxing’s choice to incorporate an independent medical review component reflects recognition of the intricacy of eligibility determinations. The review procedure allows athletes to submit comprehensive medical documentation for review by World Boxing’s Medical Committee, guaranteeing that personal situations get adequate attention. This fair-minded strategy seeks to merge clinical precision with process equity, recognising that biological sex lacks simplicity. The organisation stresses that the policy’s main aim is upholding competitive integrity whilst defending athlete welfare and dignity throughout the assessment procedure.

How the SRY genetic test operates

The SRY gene test operates by establishing the presence of a particular genetic marker that World Boxing designates as an indicator of male biological sex. The test assesses genetic material to ascertain whether the Y chromosome is detected, which typically characterises male development. According to World Boxing, this genetic marker provides an objective biological measurement that can inform eligibility decisions. The test represents a shift to scientific procedures in determining sex determination, moving away from previous approaches that were based on different criteria. Results are reviewed by impartial clinical experts who evaluate the findings in the wider clinical setting.

Athletes who show positive results for the SRY gene are not immediately disqualified; instead, they enter an appeal process allowing them to provide additional medical evidence. World Boxing’s Medical Review Board examines all provided documentation comprehensively before making final eligibility decisions. This appeals mechanism acknowledges that genetic testing alone may not provide the complete biological picture, particularly for athletes with conditions affecting sex development. The review process considers medical history, hormonal levels, and other pertinent clinical factors alongside genetic results. This comprehensive approach aims to guarantee that determinations are scientifically valid and individually appropriate rather than determined solely on single test results.

• Detects Y chromosome presence suggesting male sex determination
• Positive results activate standalone clinical assessment appeals procedure
• Clinical Panel evaluates genetic and clinical evidence in detail

The appeals process and clinical evidence

Following an initial screening in 2025, the Chinese Taipei Boxing Association initiated a formal appeal on Lin’s behalf, providing comprehensive medical documentation to World Boxing for impartial examination. The appeal mechanism is a critical safeguard within World Boxing’s qualification requirements, allowing athletes to challenge initial test results by providing relevant medical documentation. This mechanism recognises that sex classification is multifaceted and that genetic indicators alone do not provide the complete story of an individual’s medical history and biological makeup. The CTBA’s decision to pursue the challenge demonstrated confidence in Lin’s case and dedication to clearing her name through official procedures.

The submission of clinical records represented a crucial turning point in the resolution of Lin’s eligibility status. World Boxing’s medical specialists performed a comprehensive assessment of all evidence presented, taking into account not only DNA testing outcomes but also broader clinical context such as hormonal measurements, medical history, and additional pertinent physiological data. This comprehensive approach guaranteed that the decision was grounded in full clinical evaluation rather than isolated test results. The stringent examination procedure underscored World Boxing’s dedication to making decisions that are scientifically robust and individually appropriate, whilst maintaining the integrity of women’s sport.

What the medical board concluded

The World Boxing Medical Committee concluded that Lin had been female since birth and fulfilled all standards for participation in the female category, with no performance advantage. This decision came after thorough assessment of the clinical evidence and signified a definitive resolution to the eligibility matter that had dominated her career since the 2023 World Championships. The committee’s ruling affirmed Lin’s eligibility to compete at the highest levels of women’s boxing, opening the way for her comeback in international competition.

What comes next for Lin and women’s boxing

Lin’s clearance constitutes a pivotal moment not only for her career but for women’s boxing more broadly. The 30-year-old can now resume competing in World Boxing-sanctioned events after sitting out numerous competitions since the compulsory sex testing requirement was implemented in August 2025. Her return offers a possibility of regaining her status as a two-time world champion and build on her Olympic gold medal from Paris. The resolution also delivers peace of mind for the CTBA, which has consistently backed Lin throughout the disputed eligibility proceedings and celebrated the vindication of her status.

The case carries wider significance for how global sporting organisations handle eligibility policies and athlete welfare. World Boxing’s choice to establish a thorough appeals mechanism with independent medical review establishes a standard for reconciling competitive integrity with individual fairness. As Lin gets ready to compete to the ring, her return to competition will be closely watched by the boxing community and beyond, possibly shaping how other sporting bodies develop and refine their own eligibility frameworks. The pathway forward emphasises the significance of comprehensive, open procedures that respect both the science of sex determination and the human dignity of athletes.

• Lin can now compete in all World Boxing-approved international competitions with no limitations.
• The appeals procedure demonstrates World Boxing’s dedication to equitable, fact-based qualification assessments.
• Her reinstatement strengthens faith in women’s boxing administration within the new regulatory framework.